Anthera Pharmaceuticals
Earnings Date & Report
Last updated:
Anthera Pharmaceuticals’s last earnings date was on 15 May 2018. It reported its quarterly earnings per share (EPS) reaching -$0.57, falling behind the estimated value of -$0.55 by $0.02.
Anthera Pharmaceuticals stock Earnings report, Estimates & History
| 2013-07-30 | -4.91 | -3.44 |
|---|---|---|
| 2013-10-29 | -4.86 | -2.4 |
| 2014-03-12 | -3.74 | -3.84 |
| 2014-05-13 | -3.66 | -3.12 |
| 2014-07-28 | -3.92 | -2.72 |
| 2014-11-14 | -0.38 | -0.31 |
| 2015-03-16 | -0.33 | -0.32 |
| 2015-05-11 | -2.44 | -2.24 |
| 2015-08-10 | -2.2 | -2 |
| 2015-11-06 | -2.02 | -2.32 |
| 2016-03-10 | -2.12 | -1.44 |
| 2016-05-09 | -2.26 | -2.32 |
| 2016-08-09 | -2.45 | -2.8 |
| 2016-11-04 | -3 | -4.88 |
| 2017-02-27 | -3.25 | -3.2 |
| 2017-05-10 | -1.39 | -2.03 |
| 2017-08-09 | -1.09 | 0.03 |
| 2017-11-06 | -0.91 | -0.58 |
| 2018-03-05 | -0.66 | -0.73 |
| 2018-05-15 | -0.55 | -0.57 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Anthera Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 15 May 2018 | Missed | -$0.55 | -$0.57 | N/A | N/A | |
| 5 Mar 2018 | Missed | -$0.66 | -$0.73 | N/A | N/A | |
| 6 Nov 2017 | Beat | -$0.91 | -$0.58 | N/A | N/A | |
| 9 Aug 2017 | Beat | -$1.09 | $0.03 | N/A | N/A | |
| 10 May 2017 | Missed | -$1.39 | -$2.03 | N/A | N/A | |
| 27 Feb 2017 | Beat | -$3.25 | -$3.2 | N/A | N/A | |
| 4 Nov 2016 | Missed | -$3 | -$4.88 | N/A | N/A | |
| 9 Aug 2016 | Missed | -$2.45 | -$2.8 | N/A | N/A | |
| 9 May 2016 | Missed | -$2.26 | -$2.32 | 141.25K | 145K | |
| 10 Mar 2016 | Beat | -$2.12 | -$1.44 | 2.82M | 1.91M | |
| 6 Nov 2015 | Missed | -$2.02 | -$2.32 | 638.21K | 733K | |
| 10 Aug 2015 | Beat | -$2.2 | -$2 | 317.9K | 289K | |
| 11 May 2015 | Beat | -$2.44 | -$2.24 | 266.87K | 245K | |
| 16 Mar 2015 | Beat | -$0.33 | -$0.32 | N/A | N/A | |
| 14 Nov 2014 | Beat | -$0.38 | -$0.31 | N/A | N/A | |
| 28 Jul 2014 | Beat | -$3.92 | -$2.72 | N/A | N/A | |
| 13 May 2014 | Beat | -$3.66 | -$3.12 | N/A | N/A | |
| 12 Mar 2014 | Missed | -$3.74 | -$3.84 | N/A | N/A | |
| 29 Oct 2013 | Beat | -$4.86 | -$2.4 | N/A | N/A | |
| 30 Jul 2013 | Beat | -$4.91 | -$3.44 | N/A | N/A | |
Anthera Pharmaceuticals Earnings report FAQs
When is Anthera Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Anthera Pharmaceuticals's earnings date was on 10 May 2017.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.